Daniel Karp, Executive VP of Corporate Development at Organon & Co., exercised 14,184 Restricted Stock Units. The vesting resulted in a gain of shares after tax withholding.
Organon EVP Gains Shares from RSU Vesting
OrganonExecutive CompensationRestricted Stock UnitsPharmaceuticals

